drugset

drugset / Trial / NCT01225419

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children

NCT01225419 ↗

Phase 2 Completed 5 enrolled University Hospital, Clermont-Ferrand

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a prospective Phase II, monocentre study.

Timeline

Start: 2010-09
Primary completion: 2011-05
Completion: 2011-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Plerixafor	Small molecule	240 ug/kg	Subcutaneous

Indications